{
    "2014-09-04": [
        "Jake13: Opinion Click here to find out if $MRK is a",
        "US Cost of Merck's Melanoma Drug: $12,500 Per Patient Per Month, Or $150K for Year's Worth Of Treatment $MRK",
        "Per an earlier email, he pegged buyside consensus for PD-1 price at $150K/year. $MRK $BMY",
        "\"Fundamentally I believe that great drugs make great franchises.\nIt doesnt necessarily work the other way around\"-$MRK",
        "$MRK pembrolizumab APPROVED by FDA"
    ]
}